Weill Cornell Medical College - NewYork-Presbyterian Hospital
Weill Cornell Medical College - NewYork-Presbyterian Hospital
New York, New York, United States4 results · Page 1 of 1
Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Phase 3 Study of Gedatolisib as First-Line Treatment for Patients With HR-Positive, HER2-Negative Advanced Breast Cancer (VIKTORIA-2) | Neoplasm Metastasis, Neoplasms by Site, Neoplastic Processes, Pathologic Processes, Pathological Conditions, Signs and Symptoms, Skin and Connective Tissue Diseases, breast cancer, breast disorder, breast neoplasm, neoplasm, skin disorder | Recruiting | Phase 3 | 2026-10-09 | NCT06757634 | |
| A Phase 3 Efficacy and Safety Study of Fosmanogepix for the Treatment of Adult Participants With Candidemia and/or Invasive Candidiasis. | Bacterial Infections and Mycoses, Fungemia, Infections, Inflammation, Invasive Fungal Infections, Pathologic Processes, Pathological Conditions, Signs and Symptoms, Sepsis, Systemic Inflammatory Response Syndrome, Torulopsis, candidemia, candidiasis, candidiasis, invasive, fungal infectious disease | Recruiting | Phase 3 | 2026-09-14 | NCT05421858 | |
| TAP Block Timing Study | Bariatric Surgery Patients; Bariatric or General Abdominal Surgeries | Recruiting | Not applicable | 2026-01-27 | NCT07064200 | |
| E-CEL UVEC as an Adjunct Cell Therapy for Treatment of Anal Fistulas | Digestive System Diseases, Digestive System Fistula, Fistula, Pathological Conditions, Anatomical, Pathological Conditions, Signs and Symptoms, anal fistula, digestive system disorder, intestinal disorder, intestinal fistula, rectal disorder | Recruiting | Phase 1 | 2025-11-18 | NCT04190862 |